2025-04-04 - Analysis Report
## Microstrategy Inc. (MSTR) Stock Report

**0. Key Figures:**

* **Cumulative Return (MSTR):** 1325.69%
* **Cumulative Return (VOO):** 85.44%
* **Return Difference (MSTR vs VOO):** 1240.26%
* **Relative Divergence:** 60.5% (This indicates MSTR's performance is in the 60.5th percentile relative to its historical performance compared to VOO, not necessarily 60.5% better).


**1. Company Overview and Performance Comparison:**

MicroStrategy Inc. is a publicly traded business intelligence company that provides software and services for enterprise analytics and mobile intelligence.  Over the period analyzed, MSTR significantly outperformed the S&P 500 (VOO), exhibiting a vastly higher cumulative return.  The substantial divergence highlights MSTR's exceptional (but potentially volatile) performance compared to the broader market.

**Alpha and Beta Analysis:**

The provided data shows highly variable alpha and beta values across different periods.  High beta values (e.g., 10.1, 14.2, 16.4, 75.4, 73.5) indicate significant market sensitivity, while periods with negative alpha suggest underperformance relative to the market. The extremely high CAGR values and MDD values in the last few years indicate both massive returns and also high risk associated with this investment.  Note that exceptionally high CAGR values are often associated with high volatility.


| Year       | CAGR     | MDD      | Alpha   | Beta  | Cap(B) |
|------------|----------|----------|---------|-------|--------|
| 2015-2017  | -17.0%   | 29.8%   | -0.1    | 3.4   |        |
| 2016-2018  | -16.0%   | 29.8%   | 0.1     | 3.3   |        |
| 2017-2019  | -19.0%   | 29.8%   | -0.2    | 3.7   |        |
| 2018-2020  | 170.0%  | 11.2%   | -0.2    | 10.1  |        |
| 2019-2021  | 236.0%  | 28.5%   | -0.2    | 14.2  |        |
| 2020-2022  | -11.0%   | 44.9%   | -0.1    | 3.7   |        |
| 2021-2023  | -29.0%   | 44.9%   | 2.3     | 16.4  |        |
| 2022-2024  | 1455.0% | 72.9%   | 2.3     | 75.4  |        |
| 2023-2025  | 1270.0% | 72.9%   | 1.3     | 73.5  |        |


**2. Recent Price Movement:**

* **Closing Price:** $282.28
* **Previous Close:** $312.54
* **Change:** -$9.68 (a significant daily drop)
* **5-day Moving Average:** $295.70
* **20-day Moving Average:** $295.40
* **60-day Moving Average:** $315.54

The price is below all three moving averages, suggesting a possible downward trend.  The significant daily drop warrants further investigation into potential market catalysts.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.432 (Medium Risk)
* **RSI:** 45.89 (Approaching oversold territory, but not definitively so)
* **PPO:** -0.045 (Slightly bearish)
* **Recent Relative Divergence:** -10.3% (Short-term downward trend)
* **Expected Return:** 122.6% (This is a substantial projected excess return over the S&P 500 for a long-term investment, but this projection relies on assumptions about future performance, which are inherently uncertain.)

The large negative change in price (-$9.68) from the previous closing price indicates a significant, possibly abrupt, downward price movement.  This suggests that immediate market events are affecting the price.


**4. Recent Earnings Analysis:**

The provided earnings data shows consistent net losses over the period.  Revenue has remained relatively stable, but the consistently negative EPS is a major concern.

| Date       | EPS     | Revenue      |
|------------|---------|-------------|
| 2024-10-31 | -1.72   | $0.12 B     |
| 2024-08-06 | -5.74   | $0.11 B     |
| 2024-05-01 | -3.09   | $0.12 B     |
| 2023-11-01 | -10.09  | $0.13 B     |
| 2024-10-31 | -1.01   | $0.13 B     |


**5. Financial Information:**

Revenue has remained relatively consistent. Profit margins are high, which is positive. However, the negative ROE across most quarters raises serious concerns about the company's profitability and overall financial health. The significant drop in equity from Q4 2023 to Q3 2024 is also troubling.

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31 | $0.12B   | 71.69%        |
| 2024-09-30 | $0.12B   | 70.41%        |
| 2024-06-30 | $0.11B   | 72.24%        |
| 2024-03-31 | $0.12B   | 73.96%        |
| 2023-12-31 | $0.12B   | 77.33%        |

**Capital and Profitability:**

| Quarter     | Equity    | ROE          |
|-------------|-----------|--------------|
| 2024-12-31 | $18.23B   | -3.68%       |
| 2024-09-30 | $3.77B    | -9.01%       |
| 2024-06-30 | $2.83B    | -3.62%       |
| 2024-03-31 | $2.40B    | -2.21%       |
| 2023-12-31 | $2.16B    | 4.12%        |


**6. Overall Analysis:**

MSTR has shown extraordinarily high returns compared to the S&P 500 in the past, but this is accompanied by significant volatility and high risk. Recent price action, coupled with consistently negative EPS and concerning ROE figures, raises substantial red flags regarding the company's financial health. While the high profit margins are positive, the negative ROE and large equity drop need urgent attention. The high expected return projection should be viewed with extreme caution given the current financial indicators.  Further investigation into the causes of the recent price drop and the company's long-term financial sustainability is essential before making any investment decisions.  The high risk associated with this stock should be thoroughly considered.
